LncRNA Information | ||||||
---|---|---|---|---|---|---|
ID | EL0223 | Name | B4GALT1-AS1 | Aliases | N/A | |
Species | Homo sapiens | Chromosome | 9 | Start site | 33166975 | |
End site | 33179983 | Chain | plus | Exon NO. | 6 | |
Assembly | Ensembl Release 89 | Class | antisense | NCBI accession | NR_108109, NR_108110, NR_108108 | |
Ensembl | ENSG00000233554 | Sequence |
Function (not disease relevant) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Methods | Sample/condition | Expression pattern | Dysfunction type | Description | PMID | Source | |||
cap analysis of gene expression (CAGE) | normal and malignant tissues | N/A | interaction | We identified at 5'-end of B4GALT1 a 1.454 kb sequence forming a transcription regulatory region, referred to by us as the TR1-PE1, had all characteristics of a bidirectional promoter directing the transcription of B4GALT1 in a divergent manner along with its long non-coding RNA (lncRNA) antisense counterpart B4GALT1-AS1. The five lncRNA B4GALT1-AS1 transcripts showed significant complementarity with B4GALT1 mRNA. | 26315939 | ||||
Interaction | |||||||||
---|---|---|---|---|---|---|---|---|---|
Interaction target | Level of interaction | Type of interaction | Description | PMID | Source | ||||
B4GALT1 | RNA-RNA | regulation | B4GALT1 in a divergent manner along with its long non-coding RNA (lncRNA) antisense counterpart B4GALT1-AS1 | 26315939 | |||||